Hikal Q3 Results
- BSE: 524735
- NSE: HIKAL
- ISIN: INE475B01022
- Sector: Biotechnology & Drugs
BSE
373.35
13.80 (3.84%)
13.80 (3.84%)Volume29.29 K
Updated: Thu 16 Jan, 2025 | 15:29:04
NSE
373.5514.60 (4.07%)
14.60 (4.07%)Volume1.72 L
Updated: Thu 16 Jan, 2025 | 15:44:02
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Hikal Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 23 | Sep 23 | QoQ Comp | Dec 22 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 447.57 | 434.88 | 2.92% | 540.20 | -17.15% |
| Selling/ General/ Admin Expenses Total | 61.31 | 61.81 | -0.81% | 63.28 | -3.11% |
| Depreciation/ Amortization | 28.97 | 28.57 | 1.40% | 28.27 | 2.48% |
| Other Operating Expenses Total | 114.68 | 102.43 | 11.96% | 119.09 | -3.70% |
| Total Operating Expense | 411.78 | 405.93 | 1.44% | 493.89 | -16.63% |
| Operating Income | 35.79 | 28.95 | 23.63% | 46.31 | -22.72% |
| Net Income Before Taxes | 21.61 | 16.86 | 28.17% | 35.79 | -39.62% |
| Net Income | 16.14 | 12.57 | 28.40% | 26.41 | -38.89% |
| Diluted Normalized EPS | 1.31 | 1.02 | 28.43% | 2.14 | -38.79% |